| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/27/2008 | CN101249077A Preparation of degradable pollutant polyalcohol stephanoporate microballoons and uses thereof |
| 08/27/2008 | CN101249075A Preparation of water-soluble hypocrellin earth silicon nano granule based on hypocrellin nano crystal |
| 08/27/2008 | CN101249072A Method for preparing liposomes containing soya bean lecithin rhodiola rosea glycosides with melting method |
| 08/27/2008 | CN101249071A Preparation of 2-methoxyl group estradiol vena nano emulsions |
| 08/27/2008 | CN101249070A 2-methoxy estradiol vena nano emulsions |
| 08/27/2008 | CN101249069A Tilmicosin long-acting injection and method of preparing the same |
| 08/27/2008 | CN101249068A Ivermectin long-acting injection and method of preparing the same |
| 08/27/2008 | CN101249067A Anticancer sustained-release injection containing tumour medicament-resistant reverse agent and cell toxicity medicament |
| 08/27/2008 | CN101249066A Sustained-release agent containing hormone anti-cancer medicine |
| 08/27/2008 | CN101249064A Preparation of sulphonation aluminum phthalocyanine medicament chip taking polypyrole as medicament carrier |
| 08/27/2008 | CN100413904C Soluble cross-linked polyvinyl alcohol polyurethane and synthesis method thereof |
| 08/27/2008 | CN100413540C Gene carrying rack and its producing method and use |
| 08/27/2008 | CN100413506C Improved pharmaceutical compositions |
| 08/27/2008 | CN100413502C Hypertension treating medicine |
| 08/27/2008 | CN100413499C A nanoemulsion medicine of eugenol and preparation method thereof |
| 08/27/2008 | CN100413498C Drop pills of soybean aglycone, and preparation method |
| 08/27/2008 | CN100413494C Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
| 08/27/2008 | CN100413492C Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| 08/27/2008 | CN100413491C Sustained release preparation of solution resistant medicine |
| 08/27/2008 | CN100413490C Insoluble medicine transdemal absorption preparation and process for preparing same |
| 08/26/2008 | US7417118 Pharmaceutical composition containing artificial oxygen carrier |
| 08/26/2008 | US7417113 Antitumor agents; anticancer agents; antibody binding |
| 08/26/2008 | US7417110 Biocompatability; polyphosphoester/polyphosphoramidate linkages; improved gene delivery into muscles; DNA vaccines |
| 08/26/2008 | US7417109 Polymers for delivering nitric oxide in vivo |
| 08/26/2008 | US7417067 mixtures of bicyclic compounds such as lubiprostone, and triglycerides; bronchodilator agents; eye drops, capsules |
| 08/26/2008 | US7417055 Pharmacokinetics; bioavailability |
| 08/26/2008 | US7417023 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 08/26/2008 | US7417022 Amino acid for deliverying active materials; bioavailability |
| 08/26/2008 | US7417021 Biologically active conjugate of a biopolymer and therapeutic agent |
| 08/26/2008 | US7417013 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 08/26/2008 | US7416756 Recovering a phytolipid from a vegetable oil by-product by distillation, the product comprising squalene, phytosterols, mixed tocopherols and tocotrieneols, and vegetable wax; useful as an emollient and also may be incorporated into foods, beverages, and nutraceuticals |
| 08/26/2008 | US7416738 Pharmaceutical pills comprising drugs such as non-steroidal antiinflammatory agents, and cores surrounded by shells, having apertures for timed or sustained drug delivery |
| 08/26/2008 | US7416306 Laser projector |
| 08/26/2008 | CA2490299C Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof |
| 08/26/2008 | CA2441535C Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 08/26/2008 | CA2410446C Esmolol formulation |
| 08/26/2008 | CA2403441C Antimicrobial bioabsorbable materials |
| 08/26/2008 | CA2378487C Antibiotic(s)-polymer combination |
| 08/26/2008 | CA2371200C Method for production of microcapsules |
| 08/26/2008 | CA2360300C A transdermal composition of an antivomiting agent and a preparation containing the same |
| 08/26/2008 | CA2348302C Suppositories comprising hydrophobic hydroxypropyl methylcellulose |
| 08/26/2008 | CA2331465C Improvements relating to encapsulation of bioactive agents |
| 08/26/2008 | CA2323810C Ophthalmic solution comprising glycogen |
| 08/26/2008 | CA2274773C Aqueous therapeutic agents of ibuprofen |
| 08/26/2008 | CA2160779C Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 08/26/2008 | CA2159602C Stable liquid compositions of gamma interferon |
| 08/22/2008 | CA2579382A1 Controlled release delivery device |
| 08/21/2008 | WO2008101187A2 Pro-drugs of peripheral phenolic opioid antagonists |
| 08/21/2008 | WO2008101179A2 Use of sucrose to suppress mannitol-induced protein aggregation |
| 08/21/2008 | WO2008101175A2 Protein formulations containing sorbitol |
| 08/21/2008 | WO2008101173A2 Biodegradable compositions and materials |
| 08/21/2008 | WO2008100807A2 Ophthalmic compositions containing a synergistic combination of three polymers |
| 08/21/2008 | WO2008100482A2 Peptides that target to tumor blood vessels of lung cancer and applications thereof |
| 08/21/2008 | WO2008100481A2 Lung cancer-targeted peptides and applications thereof |
| 08/21/2008 | WO2008100397A1 Personal lubricant compositions that are free of glycerin and parabens |
| 08/21/2008 | WO2008100249A1 Low flush niacin formulation |
| 08/21/2008 | WO2008100230A1 Membrane(s) and uses thereof |
| 08/21/2008 | WO2008100107A1 Controlled-release preparation containing cilostazol and process for the preparation thereof |
| 08/21/2008 | WO2008099911A1 Broad-spectrum antiviral composition having excellent storage stability |
| 08/21/2008 | WO2008099906A1 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery |
| 08/21/2008 | WO2008099835A1 Band seal for hard capsules having peg encapsulated therein |
| 08/21/2008 | WO2008099800A1 Method for production of radiation diagnostic imaging agent |
| 08/21/2008 | WO2008099742A2 Ejection liquid and ejection method |
| 08/21/2008 | WO2008099615A1 Pharmaceutical composition containing fine particle oil-based suspension |
| 08/21/2008 | WO2008099190A2 Osteogenic compounds |
| 08/21/2008 | WO2008098958A1 C-terminal attachment of two chemical groups to peptides |
| 08/21/2008 | WO2008098789A2 Dual acting prodrugs |
| 08/21/2008 | WO2008098788A2 Receptor and antigen targeted prodrug |
| 08/21/2008 | WO2008098780A1 Divalent metal-ion loaded nano-transport system having a dendritic architecture useful for therapy |
| 08/21/2008 | WO2008098750A1 Pharmaceutical carrier composition and pharmaceutical composition |
| 08/21/2008 | WO2008098634A1 Dermal film-forming liquid formulations for drug release to skin |
| 08/21/2008 | WO2008098586A1 Pharmaceutical carrier composition and pharmaceutical composition |
| 08/21/2008 | WO2008098415A1 Pharmaceutical composition containing taxane and its preparation process and application |
| 08/21/2008 | WO2008098364A1 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 08/21/2008 | WO2008082613A9 Factor ix moiety-polymer conjugates having a releasable linkage |
| 08/21/2008 | WO2008081014A3 Process for manufacturing vaccines |
| 08/21/2008 | WO2008070347A3 Betulin-peptide conjugates |
| 08/21/2008 | WO2008068400A3 Method for preparing an implantable prosthesis from a porous base body and associated prosthesis and use thereof |
| 08/21/2008 | WO2008055146A9 Formulations of phospholipase enzyme inhibitors |
| 08/21/2008 | WO2007132207A3 Process for cross-linking moieties |
| 08/21/2008 | WO2007072022A3 Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 08/21/2008 | US20080200948 Novel biomaterials and a method for making and using same |
| 08/21/2008 | US20080200565 Surfactant-only microemulsions for cleaning system design and product delivery |
| 08/21/2008 | US20080200564 Copolymers Based on N-Vinylpyrrolidone and Branched Aliphatic Carbonxylic Acids, and Their Use as Solubilizers |
| 08/21/2008 | US20080200563 Non-invasive administering active materials; absorption iimproved using glutathione with active material; matric tablets, capsules |
| 08/21/2008 | US20080200562 Polymer Conjugate Enhanced Bioassays |
| 08/21/2008 | US20080200545 Peeling process with surfactants |
| 08/21/2008 | US20080200417 High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| 08/21/2008 | US20080200396 Peptides or Peptidic Conjugate Derivatives of Msh and the Use Thereof for Cosmetically Fighting Against Canities |
| 08/21/2008 | US20080200390 Exendins and Exendin Agonists Modified with Polyamino Acids |
| 08/21/2008 | US20080200377 Polyamideesters comprised of dicarboxylic acid and reaction product of diol and amino acid; drug delivery through blood vessels; controlled release, reduced adverse effects, inactivation protection, intracellular penetration enhanced pharmacological activity |
| 08/21/2008 | US20080200373 Multi-Component Biological Transport Systems |
| 08/21/2008 | US20080200372 Glycosaminoglycan Peptides Derived From Connective Tissues And Use Thereof In The Prevention Of Arthritis And Other Degenerative Medical Conditions |
| 08/21/2008 | US20080199957 therapeutic or diagnostic agent is covalently coupled to the transport agent, which is poly(2-ethylacrylic acid), poly(2-propylacrylic acid), poly(2-butylacrylic acid); drug delivery of proteins, DNA, nucleotides through endosomal membrane |
| 08/21/2008 | US20080199854 Methods and compositions for identifying RNA-binding proteins |
| 08/21/2008 | US20080199531 Methods And Products For Delivering Biological Molecules To Cells Using Multicomponent Nanostructures |
| 08/21/2008 | US20080199529 Nanoparticle delivery vehicle |
| 08/21/2008 | US20080199511 Sustained Release Compositions Containing Progesterone Receptor Modulators |
| 08/21/2008 | US20080199504 Dynamers for therapeutic agent delivery applications |